Myst Therapeutics

Acquired

Novel tumor-infiltrating lymphocyte therapies for solid tumors

Los Angeles, United States · Founded 2019

Employees
1–10
Founded
2019
Acquisition Date
Jan 2021

About

Myst Therapeutics was a privately held biotechnology company focused on developing novel tumor-infiltrating lymphocyte (TIL) T-cell therapies for solid tumors. Founded in 2019 and headquartered in Los Angeles, California, the company built a proprietary TIL technology platform aimed at advancing next-generation cancer immunotherapy. Myst Therapeutics was acquired by Turnstone Biologics Corp. in January 2021, with its TIL technology and programs absorbed into Turnstone's broader cell therapy pipeline targeting solid tumors.

Summary

Myst Therapeutics is a Biotech company based in Los Angeles, United States, founded in 2019.

Tech & App Stack

1 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionJan 2021

Similar Companies